Dela Cruz, Nenita .
HRN: 26-84-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
CEFUROXIME 1.5GM (VIAL)
03/22/2025
03/23/2025
IV
1.5g
Q8hours
S/p NSD With RMLE And Cervical Laceration Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes